These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Enuresis: principles of management and result of treatment. Kass EJ; Diokno AC; Montealegre A J Urol; 1979 Jun; 121(6):794-6. PubMed ID: 458953 [TBL] [Abstract][Full Text] [Related]
26. [The pharmacological treatment of the incontinent neurogenic bladder (author's transl)]. Herrlinger A; Schrott KM Urologe A; 1978 Sep; 17(5):349-52. PubMed ID: 706018 [TBL] [Abstract][Full Text] [Related]
27. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder. Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832 [TBL] [Abstract][Full Text] [Related]
28. Urodynamic studies in enuresis and the nonneurogenic neurogenic bladder. McGuire EJ; Savastano JA J Urol; 1984 Aug; 132(2):299-302. PubMed ID: 6737581 [TBL] [Abstract][Full Text] [Related]
29. Effects of botulinum toxin type a in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections. Pascali MP; Mosiello G; Boldrini R; Salsano ML; Castelli E; De Gennaro M J Urol; 2011 Jun; 185(6 Suppl):2552-7. PubMed ID: 21527192 [TBL] [Abstract][Full Text] [Related]
30. The role of botulinum toxin in neurourology. Schurch B Drugs Today (Barc); 2004 Mar; 40(3):205-12. PubMed ID: 15148529 [TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterases as therapeutic targets. Lin CS; Xin ZC; Lin G; Lue TF Urology; 2003 Apr; 61(4):685-91. PubMed ID: 12670544 [No Abstract] [Full Text] [Related]
32. [Changes in tonus of the bladder and its sphincter under thymoleptic treatment. Cystomanometric measurements in man]. Appel P; Eckel K; Harrer G Int Pharmacopsychiatry; 1971; 6(1):15-22. PubMed ID: 5163164 [No Abstract] [Full Text] [Related]
34. Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions. Lee YK; Kuo HC Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31450851 [TBL] [Abstract][Full Text] [Related]
35. Urinary tract disorders in children: new approaches. Retik A Hosp Pract (Off Ed); 1984 Aug; 19(8):121-7, 130-5. PubMed ID: 6430927 [No Abstract] [Full Text] [Related]
36. [Dogmatil in psychosomatic urologic diseases]. Mazeman E Lille Med; 1975 Jan; 20(1):74-5. PubMed ID: 1134176 [No Abstract] [Full Text] [Related]
37. Postmenopausal urinary problems. Brown AD Clin Obstet Gynaecol; 1977 Apr; 4(1):181-206. PubMed ID: 558076 [TBL] [Abstract][Full Text] [Related]
38. [Treatment of urinary incontinence in neurogenic bladder]. da Silva Peres OR Rev Bras Med; 1969 Apr; 26(4):251-2. PubMed ID: 5800218 [No Abstract] [Full Text] [Related]
39. [How come? What for? Why? Questions on the topic of "Botulinum toxin in urology"]. Schulte-Baukloh H; Knispel HH Urologe A; 2007 Sep; 46(9):1210-1. PubMed ID: 17690862 [No Abstract] [Full Text] [Related]